1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Molecular Diagnostics for Infectious Disease Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Molecular Diagnostics for Infectious Disease Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Molecular Diagnostics for Infectious Disease Market Regional Analysis
6.2 Europe Molecular Diagnostics for Infectious Disease Market Revenue 2020-2030 (US$ Million)
6.3 Europe Molecular Diagnostics for Infectious Disease Market Forecast Analysis
7. Europe Molecular Diagnostics for Infectious Disease Market Analysis – by Type
7.1 Point-of-Care Testing and Laboratory Testing
- 7.1.1 Overview
- 7.1.2 Point-of-Care Testing and Laboratory Testing: Europe Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. Europe Molecular Diagnostics for Infectious Disease Market Analysis – by End User
8.1 Human Testing and Vet Testing
- 8.1.1 Overview
- 8.1.2 Human Testing and Vet Testing: Europe Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. Europe Molecular Diagnostics for Infectious Disease Market Analysis – by Application
9.1 Detection of Single Pathogen
- 9.1.1 Overview
- 9.1.2 Detection of Single Pathogen: Europe Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Detection of Two or More Pathogens
- 9.2.1 Overview
- 9.2.2 Detection of Two or More Pathogens: Europe Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Evaluation of Emerging Novel Infections
- 9.3.1 Overview
- 9.3.2 Evaluation of Emerging Novel Infections: Europe Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.4 Surveillance and Early Detection of Biothreat Agents and Diseases-Related Biomarker
- 9.4.1 Overview
- 9.4.2 Surveillance and Early Detection of Biothreat Agents and Diseases-Related Biomarker: Europe Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.5 Antimicrobial Resistance Profiling
- 9.5.1 Overview
- 9.5.2 Antimicrobial Resistance Profiling: Europe Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.6 Patient stratification
- 9.6.1 Overview
- 9.6.2 Patient stratification: Europe Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.7 Drug Regimen Selection
- 9.7.1 Overview
- 9.7.2 Drug Regimen Selection: Europe Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.8 Toxicity Avoidance
- 9.8.1 Overview
- 9.8.2 Toxicity Avoidance: Europe Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.9 Therapeutic Monitoring
- 9.9.1 Overview
- 9.9.2 Therapeutic Monitoring: Europe Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.10 Detection of Predisposition to Disease
- 9.10.1 Overview
- 9.10.2 Detection of Predisposition to Disease: Europe Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. Europe Molecular Diagnostics for Infectious Disease Market Analysis – by Disease Type
10.1 Sepsis
- 10.1.1 Overview
- 10.1.2 Sepsis: Europe Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.2 Prosthetic Joint Infection
- 10.2.1 Overview
- 10.2.2 Prosthetic Joint Infection: Europe Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.3 Endocarditis
- 10.3.1 Overview
- 10.3.2 Endocarditis: Europe Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.4 STDs
- 10.4.1 Overview
- 10.4.2 STDs: Europe Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.5 Mononucleosis
- 10.5.1 Overview
- 10.5.2 Mononucleosis: Europe Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.6 Group A Streptococcus
- 10.6.1 Overview
- 10.6.2 Group A Streptococcus: Europe Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.7 Sepsis
- 10.7.1 Overview
- 10.7.2 Sepsis: Europe Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.8 Prosthetic Joint Infection
- 10.8.1 Overview
- 10.8.2 Prosthetic Joint Infection: Europe Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.9 Endocarditis
- 10.9.1 Overview
- 10.9.2 Endocarditis: Europe Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.10 STDs
- 10.10.1 Overview
- 10.10.2 STDs: Europe Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.11 Chlamydia
- 10.11.1 Overview
- 10.11.2 Chlamydia: Europe Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.12 Gastrointestinal Infection
- 10.12.1 Overview
- 10.12.2 Gastrointestinal Infection: Europe Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.13 Tuberculosis
- 10.13.1 Overview
- 10.13.2 Tuberculosis: Europe Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.14 H1N1 Virus
- 10.14.1 Overview
- 10.14.2 H1N1 Virus: Europe Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast, 2020-2030 (US$ Million)
11. Europe Molecular Diagnostics for Infectious Disease Market – Europe Analysis
11.1 Overview
11.2 Europe
- 11.2.1 Europe Molecular Diagnostics for Infectious Disease Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 11.2.1.1 Europe Molecular Diagnostics for Infectious Disease Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 UK:
Europe Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.1.1 UK: Europe Molecular Diagnostics for Infectious Disease Market Breakdown, by Type
- 11.2.1.1.2 UK: Europe Molecular Diagnostics for Infectious Disease Market Breakdown, by End User
- 11.2.1.1.3 UK: Europe Molecular Diagnostics for Infectious Disease Market Breakdown, by Application
- 11.2.1.1.4 UK: Europe Molecular Diagnostics for Infectious Disease Market Breakdown, by Disease Type
- 11.2.1.2 Germany:
Europe Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.2.1 Germany: Europe Molecular Diagnostics for Infectious Disease Market Breakdown, by Type
- 11.2.1.2.2 Germany: Europe Molecular Diagnostics for Infectious Disease Market Breakdown, by End User
- 11.2.1.2.3 Germany: Europe Molecular Diagnostics for Infectious Disease Market Breakdown, by Application
- 11.2.1.2.4 Germany: Europe Molecular Diagnostics for Infectious Disease Market Breakdown, by Disease Type
- 11.2.1.3 France:
Europe Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.3.1 France: Europe Molecular Diagnostics for Infectious Disease Market Breakdown, by Type
- 11.2.1.3.2 France: Europe Molecular Diagnostics for Infectious Disease Market Breakdown, by End User
- 11.2.1.3.3 France: Europe Molecular Diagnostics for Infectious Disease Market Breakdown, by Application
- 11.2.1.3.4 France: Europe Molecular Diagnostics for Infectious Disease Market Breakdown, by Disease Type
- 11.2.1.4 Russia:
Europe Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.4.1 Russia: Europe Molecular Diagnostics for Infectious Disease Market Breakdown, by Type
- 11.2.1.4.2 Russia: Europe Molecular Diagnostics for Infectious Disease Market Breakdown, by End User
- 11.2.1.4.3 Russia: Europe Molecular Diagnostics for Infectious Disease Market Breakdown, by Application
- 11.2.1.4.4 Russia: Europe Molecular Diagnostics for Infectious Disease Market Breakdown, by Disease Type
- 11.2.1.5 Italy:
Europe Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.5.1 Italy: Europe Molecular Diagnostics for Infectious Disease Market Breakdown, by Type
- 11.2.1.5.2 Italy: Europe Molecular Diagnostics for Infectious Disease Market Breakdown, by End User
- 11.2.1.5.3 Italy: Europe Molecular Diagnostics for Infectious Disease Market Breakdown, by Application
- 11.2.1.5.4 Italy: Europe Molecular Diagnostics for Infectious Disease Market Breakdown, by Disease Type
- 11.2.1.6 Rest of Europe:
Europe Molecular Diagnostics for Infectious Disease Market – Revenue and Forecast to 2030 (US$ Million)
- 11.2.1.6.1 Rest of Europe: Europe Molecular Diagnostics for Infectious Disease Market Breakdown, by Type
- 11.2.1.6.2 Rest of Europe: Europe Molecular Diagnostics for Infectious Disease Market Breakdown, by End User
- 11.2.1.6.3 Rest of Europe: Europe Molecular Diagnostics for Infectious Disease Market Breakdown, by Application
- 11.2.1.6.4 Rest of Europe: Europe Molecular Diagnostics for Infectious Disease Market Breakdown, by Disease Type
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Abbott Laboratories
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 bioMerieux SA
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Bruker Corp
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Danaher Corp
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 DiaSorin SpA
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 F. Hoffmann-La Roche Ltd
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Hologic Inc
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Molzym GmbH & Co KG
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Siemens Healthineers AG
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Thermo Fisher Scientific Inc
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Get Free Sample For Europe Molecular Diagnostics for Infectious Disease Market
